제품 정보로 건너뛰기
1 1

AntibodySystem

SKU(재고 관리 코드):DHD47901

Research Grade Bemarituzumab

Research Grade Bemarituzumab

Title

Catalog No.: DHD47901

Catalog No. DHD47901
Product name Research Grade Bemarituzumab
Size 100 μg
Species reactivity Human
Host species Humanized
Isotype IgG1-kappa
Applications Research Grade Biosimilar
Description Bemarituzumab (bema), a first-in-class humanized IgG1 monoclonal antibody, selectively binds to 2b Isoform of thefibroblast growth factor receptor (FGFR2b). Bemarituzumab (FPA144) is a first-in-class humanized immunoglobulin G1 monoclonal antibody specific to the splice-variant FGFR2b that inhibits binding of the ligands FGF7, FGF10, and FGF22. Specifically, bemarituzumab does not inhibit binding of FGF23, the ligand responsible for phosphate and vitamin D metabolism, thereby potentially avoiding the risk of hyperphosphatemia associated with pan-FGFR tyrosine kinase inhibitors. Bemarituzumab is also glycoengineered for increased affinity for the human Fc gamma RIIIA receptor expressed on natural killer cells, enabling enhanced antibody-dependent cell_x0002_mediated cytotoxicity.
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Purity >95% as determined by SDS-PAGE.
Clonality Monoclonal
Target K-sam, KSAM, CD332, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR-2, FGFR2, KGFR, BEK
Purification Protein A/G purified from cell culture supernatant.
Endotoxin level Please contact with the lab for this information.
Accession P21802
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names FPA144 ,FPA-144, FPA114-A, CAS: 1952272-74-0
Clone ID Bemarituzumab
Note For research use only. Not suitable for clinical or therapeutic use.
전체 세부 정보 보기